DiaMedica Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $44.0M | $4.7M |
| FY2022 | — | $31.8M | $4.7M |
| FY2023 | — | $51.1M | $4.5M |
| FY2024 | — | $40.7M | $3.0M |
| FY2025 | — | $56.1M | $15.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $44.0M | $4.7M |
| FY2022 | — | $31.8M | $4.7M |
| FY2023 | — | $51.1M | $4.5M |
| FY2024 | — | $40.7M | $3.0M |
| FY2025 | — | $56.1M | $15.6M |